These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 20442687)

  • 1. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines.
    Moon SS; Wang Y; Shane AL; Nguyen T; Ray P; Dennehy P; Baek LJ; Parashar U; Glass RI; Jiang B
    Pediatr Infect Dis J; 2010 Oct; 29(10):919-23. PubMed ID: 20442687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries.
    Moon SS; Tate JE; Ray P; Dennehy PH; Archary D; Coutsoudis A; Bland R; Newell ML; Glass RI; Parashar U; Jiang B
    Pediatr Infect Dis J; 2013 Aug; 32(8):863-70. PubMed ID: 23584581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines.
    Trang NV; Braeckman T; Lernout T; Hau VT; Anh le TK; Luan le T; Van Damme P; Anh DD
    Hum Vaccin Immunother; 2014; 10(12):3681-7. PubMed ID: 25668672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
    Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
    Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants.
    Bautista-Marquez A; Velasquez DE; Esparza-Aguilar M; Luna-Cruz M; Ruiz-Moran T; Sugata K; Jiang B; Parashar U; Patel M; Richardson V
    Vaccine; 2016 Oct; 34(44):5284-5289. PubMed ID: 27663670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
    PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
    Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
    Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.
    Ali A; Kazi AM; Cortese MM; Fleming JA; Moon S; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi AK
    PLoS One; 2015; 10(6):e0127622. PubMed ID: 26035743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
    Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
    Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
    Kazimbaya KM; Chisenga CC; Simuyandi M; Phiri CM; Laban NM; Bosomprah S; Permar SR; Munsaka S; Chilengi R
    PLoS One; 2020; 15(11):e0240714. PubMed ID: 33170860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial.
    Rongsen-Chandola T; Winje BA; Goyal N; Rathore SS; Mahesh M; Ranjan R; Arya A; Rafiqi FA; Bhandari N; Strand TA
    Trials; 2014 Jun; 15():256. PubMed ID: 24976452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa.
    Groome MJ; Moon SS; Velasquez D; Jones S; Koen A; van Niekerk N; Jiang B; Parashar UD; Madhi SA
    Bull World Health Organ; 2014 Apr; 92(4):238-45. PubMed ID: 24700991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine.
    Liu GF; Hille D; Kaplan SS; Goveia MG
    Hum Vaccin Immunother; 2017 Oct; 13(10):2357-2363. PubMed ID: 28836489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus serotype-specific neutralizing activity in human milk.
    Bell LM; Clark HF; Offit PA; Slight PH; Arbeter AM; Plotkin SA
    Am J Dis Child; 1988 Mar; 142(3):275-8. PubMed ID: 2830785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.
    Ella R; Bobba R; Muralidhar S; Babji S; Vadrevu KM; Bhan MK
    Hum Vaccin Immunother; 2018 Jul; 14(7):1791-1799. PubMed ID: 29543547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants.
    Appaiahgari MB; Glass R; Singh S; Taneja S; Rongsen-Chandola T; Bhandari N; Mishra S; Vrati S
    Vaccine; 2014 Feb; 32(6):651-6. PubMed ID: 24374502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    Levin MJ; Lindsey JC; Kaplan SS; Schimana W; Lawrence J; McNeal MM; Bwakura-Dangarembizi M; Ogwu A; Mpabalwani EM; Sato P; Siberry G; Nelson M; Hille D; Weinberg GA; Weinberg A
    AIDS; 2017 Jan; 31(1):49-59. PubMed ID: 27662551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine.
    Chattha KS; Vlasova AN; Kandasamy S; Esseili MA; Siegismund C; Rajashekara G; Saif LJ
    Vaccine; 2013 Apr; 31(15):1916-23. PubMed ID: 23453730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.